Results 31 to 40 of about 5,280 (85)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI). [PDF]

open access: yesFrontline Gastroenterol, 2022
Brennan PN   +3 more
europepmc   +1 more source

Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI). [PDF]

open access: yesStem Cell Res Ther, 2022
Miyata S   +14 more
europepmc   +1 more source

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. [PDF]

open access: yesAntioxidants (Basel), 2021
Villanueva-Paz M   +6 more
europepmc   +1 more source

S2840 Drug-Induced Liver Injury (DILI) Secondary to Kratom Use

open access: yesAmerican Journal of Gastroenterology, 2021
Gopala Koneru   +4 more
openaire   +3 more sources

Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)

open access: yes, 2017
The aim of the presented PhD thesis was the development of a new in vitro test system which allows for a better characterization and prediction of drug- induced liver injuries (DILI). After the initial damage of hepatocytes, the activation of the immune system can aggravate this damage and lead to severe liver failure. This important interaction should
openaire   +2 more sources

A Rare Case of Drug-Induced Liver Injury (DILI) From Topiramate. [PDF]

open access: yesCureus
Macasaet R   +5 more
europepmc   +1 more source

Autoimmune Hepatitis (AIH) Related to Drug-Induced Liver Injury (DILI) Due to Atorvastatin. [PDF]

open access: yesCureus
Loeza-Suárez J   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy